TJ202, Lenalidomide and Dexamethasone vs. Lenalidomide and Dexamethasone in Subjects With Relapsed or Refractory Multiple Myeloma

Clinical trial NCT03952091 · COMPLETED

Trial details

NCT number: NCT03952091
Sponsor: TJ Biopharma Co., Ltd.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Multiple Myeloma in Relapse Refractory Multiple Myeloma

Start date: 2019-03-27
Primary completion: 2024-06-30
Enrollment: 289

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.